UKCCCR RANDOMISED TRIAL OF ADJUVANT ENDOCRINE THERAPY AND CHEMOTHERAPY IN WOMEN WITH EARLY BREAST CANCER, THE ADJUVANT BREAST CANCER (ABC) TRIAL

Trial Profile

UKCCCR RANDOMISED TRIAL OF ADJUVANT ENDOCRINE THERAPY AND CHEMOTHERAPY IN WOMEN WITH EARLY BREAST CANCER, THE ADJUVANT BREAST CANCER (ABC) TRIAL

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2014

At a glance

  • Drugs Tamoxifen (Primary) ; Cyclophosphamide; Cyclophosphamide; Doxorubicin; Fluorouracil; Goserelin; Leuprorelin; Methotrexate
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms ABC
  • Most Recent Events

    • 21 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 04 Apr 2007 Primary endpoint 'Overall-survival-rate' has been met.
    • 25 Jul 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top